drugset / Trial / NCT02785003

Ketamine in Colorectal Surgery

NCT02785003

Phase 4 Withdrawn Medical College of Wisconsin
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the effectiveness of ketamine infusions in the management of acute pain following open or laparoscopic colorectal surgery cases. Half of patients will receive the institutional standard of care and a placebo infusion (no active medication). The other half of patients will receive the institutional standard of care and a ketamine infusion. All subjects and staff will be blinded as to whether they are receiving placebo or ketamine.

Timeline

Start
2016-07
Primary completion
2017-08
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 2 ug/kg Intravenous
Background Acetaminophen Small molecule 650 mg Oral
Background Acetaminophen Small molecule 1000 mg Oral
Background Alvimopan Small molecule
Background Hydromorphone Other / unclassified
Background Morphine Other / unclassified

Indications